(19)
(11) EP 1 175 443 A1

(12)

(43) Date of publication:
30.01.2002 Bulletin 2002/05

(21) Application number: 00928685.7

(22) Date of filing: 28.04.2000
(51) International Patent Classification (IPC)7C07K 14/575, A61K 47/48
(86) International application number:
PCT/US0011/814
(87) International publication number:
WO 0066/629 (09.11.2000 Gazette 2000/45)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 30.04.1999 US 132018 P

(71) Applicant: AMYLIN PHARMACEUTICALS, INC.
San Diego, California 92121 (US)

(72) Inventors:
  • YOUNG, Andrew
    Point Loma, CA 92166 (US)
  • PRICKETT, Kathryn
    San Diego, CA 92126 (US)

(74) Representative: Duckworth, Timothy John 
J.A. Kemp & Co., 14 South Square, Gray's Inn
London WC1R 5JJ
London WC1R 5JJ (GB)

   


(54) MODIFIED EXENDINS AND EXENDIN AGONISTS